Treating Reward Deficiency Syndrome (RDS) with a nutrigenomic dopaminergic brain activator by targeting reward gene polymorphisms utilizing genetic algorithms
obese subjects identified in the Netherlands was administered various KB220 formulae customized according to respective DNA polymorphisms. Patients attending seven diverse treatment centers n=273 who completed the…

